Intelligent Investing News
Intelligent Investing News
|
4-Star Stocks Poised to Pop: 3SBio (at Motley Fool)
|
|
|
AMAG Anemia Drug Eyes Growing Market (Investor's Business Daily, Inc.)
|
Most biotech firms bet their future on only one drug. AMAG Pharmaceuticals is no exception. The company relies heavily on Feraheme, a new IV injection treatment for iron-deficiency anemia in adult patients with chronic kidney disease.
|
|
AMAG PHARMACEUTICALS INC. Financials (EDGAR Online Financials)
|
|
|
AMAG Pharmaceuticals, Inc. to Present at the Cowen and Company 30th Annual Healthcare Conference (Business Wire)
|
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that Brian J.G. Pereira, MD, President and CEO, will present an overview of the Company at the Cowen and Company 30th Annual Healthcare Conference on March 9 at 3:45 p.m.
|
|
Narrower Q4 Loss for AMAG (Zacks.com)
|
|
|
Passport Capital Hedges With ETFs and Options (at Seeking Alpha)
|
|
|
AMAG Pharmaceuticals, Inc. Earnings Call scheduled for 8:00 am ET today (CCBN)
|
|
|
Wall Street Breakfast: Must-Know News (at Seeking Alpha)
|
|
|
AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (EDGAR Online)
|
|
|
AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results (Business Wire)
|
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.
|
|
AMAG PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report (EDGAR Online)
|
|
|
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2009 (Business Wire)
|
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced it will report unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009 before the U.S. financial markets open on March 1, 2010.
|
|
AMAG Defends Feraheme Safety: BioBuzz (at TheStreet.com)
|
|
|
AMAG Pharmaceuticals, Inc. Provides Feraheme® Safety Update Call scheduled for 4:45 pm ET today (CCBN)
|
|
|
AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
|
|
|
AMAG Pharmaceuticals Provides Feraheme® Safety Update (Business Wire)
|
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® Injection for intravenous use.
|
|
Iron Safety Hits AMAG Pharmaceuticals (at Seeking Alpha)
|
|
|
Thursday Options Update: GFI, SU, MA, ZION, DAL, AMAG & JWN (at Seeking Alpha)
|
|
|
AMAG Pharma Tumbles on Feraheme Safety Concerns: BioBuzz (at TheStreet.com)
|
|
|
Recent Dividend Hikes May Point to a Return to Normalcy (at Seeking Alpha)
|
|
Intelligent Investing News
Intelligent Investing News
